Skip to main content
Amy Norman

Amy Norman

Patient advocate and parent from the West Midlands; mother of Imogen, who accessed teplizumab through the ELSA type 1 diabetes screening study

Jul 6, 2026

NicolinaHOST
11:41
And I guess what could also happen if we don't do it the right way or if we don't put a little more thought into how we're doing it?
11:49
Yeah.
11:49
I mean, everything is impacted.
11:51
Even your vision reduces during breastfeeding.
11:53
So that's always a little bit of trivia.
11:55
We go, oh my gosh, literally everything is getting impacted by breastfeeding.
11:59
But yes, ergonomics is super important.

9 MINS LATER

NicolinaHOST
21:05
Can you explain, I guess, what it can help with when it comes to babies?
4:23
What gave you the confidence to go ahead with that?
4:26
The consultant at Birmingham Children's Hospital let us know that she's actually at stage two.
4:30
I said to the consultant at the time, what is there available? We discussed how much that's a huge opportunity for us to be able to kind of give Imogen a chance to delay it or even kind of stop it from even happening and I inquired about any kind of trials or kind of any that we can sign her up to and that's when her consultant mentioned to me about teplizumab it sounded incredible in fact I had to get her consultant to write it down so then I went away and did lots of research about what it meant and what it looked like and What's the evidence behind it? As a type 1 diabetic myself, I know the difficulties of living with type 1 diabetes.
5:09
When I was diagnosed when I was 13 was difficult and I didn't want her to experience that.
5:14
Adolescence is already difficult.
5:16
So I was trying to make that experience easier for her.
5:19
And it was just a waiting game then to see whether she would be in the line to be able to have it.
5:32
What was that experience like day to day for you and your family?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.